Formulation of aluminum hydroxide adjuvant with TLR agonists poly(I:C) and CpG enhances the magnitude and avidity of the humoral immune response
Lu, Fangjia, Mosley, Yung-Yi C., Carmichael, Brooke, Brown, Devonte D., HogenEsch, HarmLanguage:
english
Journal:
Vaccine
DOI:
10.1016/j.vaccine.2019.02.033
Date:
February, 2019
File:
PDF, 1.93 MB
english, 2019